sulfinpyrazone has been researched along with Ureteral Calculi in 1 studies
Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.
Ureteral Calculi: Stones in the URETER that are formed in the KIDNEY. They are rarely more than 5 mm in diameter for larger renal stones cannot enter ureters. They are often lodged at the ureteral narrowing and can cause excruciating renal colic.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kovalchik, MT | 1 |
1 other study available for sulfinpyrazone and Ureteral Calculi
| Article | Year |
|---|---|
Sulfinpyrazone induced uric acid urolithiasis with acute renal failure.
Topics: Acute Kidney Injury; Female; Humans; Middle Aged; Sulfinpyrazone; Ureteral Calculi; Uric Acid | 1981 |